Pricing Log in Create free account

Ardelyx, Inc. (ARDX) vs Cullinan Therapeutics, Inc. (CGEM)

Ardelyx, Inc. and Cullinan Therapeutics, Inc. are both Biotechnology companies. Ardelyx, Inc. and Cullinan Therapeutics, Inc. are of similar size ($751.6M and $695.0M). Cullinan Therapeutics, Inc. has the higher net margin (0.00% vs −11.9%) and the higher return on invested capital (0.00% vs −17.2%). Across the 13 metrics below, Cullinan Therapeutics, Inc. leads on 9 and Ardelyx, Inc. on 4.

Valuation

Metric ARDX CGEM Biotechnology median
P/E n/m n/m 10.60
P/S 1.53 n/m 9.40
P/B 4.36 2.17 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.51 n/m 9.02
Earnings yield (7.79%) (27.34%) (32.88%)
Free cash flow yield (2.23%) (22.84%) (23.13%)

Profitability

Metric ARDX CGEM Biotechnology median
Gross margin 94.46% — 68.51%
Operating margin (7.71%) 0.00% 0.00%
Net margin (11.85%) 0.00% 0.00%
Free cash flow margin (3.41%) 0.00% 0.00%
Return on equity (34.85%) (50.30%) (51.96%)
Return on assets (10.33%) (46.30%) (46.06%)
Return on invested capital (17.21%) 0.00% 0.00%

Growth

Metric ARDX CGEM Biotechnology median
Revenue growth (TTM) 17.57% — 6.76%
EPS growth (last fiscal year) (52.94%) (20.86%) 29.88%
Revenue growth, 5-year CAGR 121.90% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARDX CGEM Biotechnology median
Debt to equity 1.54 0.00 0.00
Current ratio 3.45 8.42 4.97
Net debt to EBITDA 1.63 1.57 1.01

Dividend

Metric ARDX CGEM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARDX CGEM Biotechnology median
Market cap 751.61m 695.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack